AAAAAA

   
Results: 1-16 |
Results: 16
Does ascorbic acid prevent retinopathy during interferon therapy in patients with chronic hepatitis C?
Authors: Nishiguchi, S Shiomi, S Enomoto, M Lee, C Jomura, H Tamori, A Habu, D Takeda, T Yanagihara, N Shiraki, K
Citation: S. Nishiguchi et al., Does ascorbic acid prevent retinopathy during interferon therapy in patients with chronic hepatitis C?, J GASTRO, 36(7), 2001, pp. 486-491
Mesenteric desmoid with uptake on gallium-67 citrate scintigraphy
Authors: Shiomi, S Nishiguchi, S Montani, A Ishizu, H Iwata, Y Sasaki, N Habu, D Kawabe, J Ochi, H
Citation: S. Shiomi et al., Mesenteric desmoid with uptake on gallium-67 citrate scintigraphy, ANN NUCL M, 15(3), 2001, pp. 251-253
A case of glucagonoma with high uptake on F-18 fluorodeoxyglucose positronemission tomography
Authors: Nishiguchi, S Shiomi, S Ishizu, H Iwata, Y Kurooka, H Ninamitani, S Habu, D Kawabe, J Ochi, H
Citation: S. Nishiguchi et al., A case of glucagonoma with high uptake on F-18 fluorodeoxyglucose positronemission tomography, ANN NUCL M, 15(3), 2001, pp. 259-262
Accessory spleen in the pelvis diagnosed by Tc-99m phytate scintigraphy
Authors: Nishiguchi, S Habu, D Ishizu, H Iwata, Y Tatsumi, N Enomoto, M Minamitani, S Fukuda, K Tamori, A Takeda, T Shiomi, S Kawabe, J Ochi, H
Citation: S. Nishiguchi et al., Accessory spleen in the pelvis diagnosed by Tc-99m phytate scintigraphy, ANN NUCL M, 15(3), 2001, pp. 263-265
Method to detect substitutions in the interferon-sensitivity-determining region of hepatitis C virus 1b for prediction of response to interferon therapy
Authors: Nishiguchi, S Ueda, T Itoh, T Enomoto, M Tanaka, M Tatsumi, N Fukuda, K Tamori, A Habu, D Takeda, T Otani, S Shiomi, S
Citation: S. Nishiguchi et al., Method to detect substitutions in the interferon-sensitivity-determining region of hepatitis C virus 1b for prediction of response to interferon therapy, HEPATOLOGY, 33(1), 2001, pp. 241-247
Randomized pilot trial of vitamin K-2 for bone loss in patients with primary biliary cirrhosis
Authors: Nishiguchi, S Shimoi, S Kurooka, H Tamori, A Habu, D Takeda, T Kubo, S
Citation: S. Nishiguchi et al., Randomized pilot trial of vitamin K-2 for bone loss in patients with primary biliary cirrhosis, J HEPATOL, 35(4), 2001, pp. 543-545
Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosis
Authors: Nishiguchi, S Shiomi, S Nakatani, S Takeda, T Fukuda, K Tamori, A Habu, D Tanaka, T
Citation: S. Nishiguchi et al., Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosis, LANCET, 357(9251), 2001, pp. 196-197
Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose for predicting outcome in patients with hepatocellular carcinoma
Authors: Shiomi, S Nishiguchi, S Ishizu, H Iwata, Y Sasaki, N Tamori, A Habu, D Takeda, T Kubo, S Ochi, H
Citation: S. Shiomi et al., Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose for predicting outcome in patients with hepatocellular carcinoma, AM J GASTRO, 96(6), 2001, pp. 1877-1880
Outcomes of dysplastic nodules in human cirrhotic liver: A clinicopathological study
Authors: Seki, S Sakaguchi, H Kitada, T Tamori, A Takeda, T Kawada, N Habu, D Nakatani, K Nishiguchi, S Shiomi, S
Citation: S. Seki et al., Outcomes of dysplastic nodules in human cirrhotic liver: A clinicopathological study, CLIN CANC R, 6(9), 2000, pp. 3469-3473
Assessment of hepatic blood flow by PET with O-15 water: Correlation between per-rectal portal scintigraphy with Tc-99(m)-pertechnetate and scintigraphy with Tc-99(m)-GSA
Authors: Shiomi, S Iwata, Y Sasaki, N Morikawa, H Tamori, A Habu, D Takeda, T Nishiguchi, S Kuroki, T Ochi, H
Citation: S. Shiomi et al., Assessment of hepatic blood flow by PET with O-15 water: Correlation between per-rectal portal scintigraphy with Tc-99(m)-pertechnetate and scintigraphy with Tc-99(m)-GSA, NUCL MED C, 21(6), 2000, pp. 533-538
Laparoscopic microwave coagulation therapy for hepatocellular carcinoma
Authors: Seki, S Sakaguchi, H Kadoya, H Morikawa, H Habu, D Nishiguchi, S Shiomi, S Kitada, T Kuroki, T
Citation: S. Seki et al., Laparoscopic microwave coagulation therapy for hepatocellular carcinoma, ENDOSCOPY, 32(8), 2000, pp. 591-597
Calcitriol for bone loss in patients with primary biliary cirrhosis
Authors: Shiomi, S Masaki, K Habu, D Takeda, T Nishiguchi, S Kuroki, T Ochi, H
Citation: S. Shiomi et al., Calcitriol for bone loss in patients with primary biliary cirrhosis, J GASTRO, 34(2), 1999, pp. 241-245
Clinical usefulness of conjugated bilirubin levels in patients with acute liver diseases
Authors: Shiomi, S Habu, D Kuroki, T Ishida, S Tatsumi, N
Citation: S. Shiomi et al., Clinical usefulness of conjugated bilirubin levels in patients with acute liver diseases, J GASTRO, 34(1), 1999, pp. 88-93
Clinical need for both scintigraphy with technetium-99m GSA and per-rectalportal scintigraphy in some patients with chronic liver disease
Authors: Shiomi, S Iwata, Y Sasaki, N Kurooka, H Tamori, A Habu, D Takeda, T Nishiguchi, S Kuroki, T Ochi, H
Citation: S. Shiomi et al., Clinical need for both scintigraphy with technetium-99m GSA and per-rectalportal scintigraphy in some patients with chronic liver disease, ANN NUCL M, 13(4), 1999, pp. 241-245
Calcitriol for bone disease in patients with cirrhosis of the liver
Authors: Shiomi, S Masaki, K Habu, D Takeda, T Nishiguchi, S Kuroki, T Tanaka, T Ochi, H
Citation: S. Shiomi et al., Calcitriol for bone disease in patients with cirrhosis of the liver, J GASTR HEP, 14(6), 1999, pp. 547-552
Use of scintigraphy with (99m)technetium galactosyl human serum albumin for staging of primary biliary cirrhosis and assessment of prognosis
Authors: Shiomi, S Sasaki, N Tamori, A Habu, D Takeda, T Nishiguchi, S Kuroki, T Kawabe, J Ochi, H
Citation: S. Shiomi et al., Use of scintigraphy with (99m)technetium galactosyl human serum albumin for staging of primary biliary cirrhosis and assessment of prognosis, J GASTR HEP, 14(6), 1999, pp. 566-571
Risultati: 1-16 |